Clinicostatistical study of renal pelvic and ureteral tumors

J. Ochi, T. Tsushima, K. Kobashi, M. Hara, Yasutomo Nasu, Y. Matsumura, H. Ohmori, T. Asahi, K. Takeda, T. Oheda, T. Josen, T. Shiraga, N. Ike, T. Akaeda, K. Nanba, T. Tanahashi, H. Takamoto, N. Akazawa, S. Hayata

Research output: Contribution to journalArticle

Abstract

From 1975 to 1984, 190 patients with renal pelvic tumor and ureteral tumor were treated at our hospitals. With reference to those cases (renal pelvic tumor, 85 cases; ureteral tumor, 83 cases; renal pelvic and ureteral tumor, 22 cases), mainly the effects of adjuvant chemotherapy were analyzed in this study. The survival rate of all the cases was 54.5% at 5 years. To evaluate the effects of adjuvant chemotherapy, the survival rates of two groups (those with or without adjuvant chemotherapy) were compared. For the patients (M(o), (p)T(a)~(p)T4), the survival rates at 5 years were 67.8% for the chemotherapy (+) group and 50.7% for the chemotherapy (-) group. There was no significant difference between the two groups. For the patients (M(o), (p)T(a)~(p)T2), the survival rates were 80.6% and 48.5%, respectively and there was a significant difference (p2, G3) the survival rates were 81.4% and 0%, respectively, and this showed an even more significant difference (p

Original languageEnglish
Pages (from-to)38-43
Number of pages6
JournalNishinihon Journal of Urology
Volume56
Issue number1
Publication statusPublished - 1994

Fingerprint

Survival Rate
Kidney
Adjuvant Chemotherapy
Neoplasms
Drug Therapy

ASJC Scopus subject areas

  • Urology

Cite this

Ochi, J., Tsushima, T., Kobashi, K., Hara, M., Nasu, Y., Matsumura, Y., ... Hayata, S. (1994). Clinicostatistical study of renal pelvic and ureteral tumors. Nishinihon Journal of Urology, 56(1), 38-43.

Clinicostatistical study of renal pelvic and ureteral tumors. / Ochi, J.; Tsushima, T.; Kobashi, K.; Hara, M.; Nasu, Yasutomo; Matsumura, Y.; Ohmori, H.; Asahi, T.; Takeda, K.; Oheda, T.; Josen, T.; Shiraga, T.; Ike, N.; Akaeda, T.; Nanba, K.; Tanahashi, T.; Takamoto, H.; Akazawa, N.; Hayata, S.

In: Nishinihon Journal of Urology, Vol. 56, No. 1, 1994, p. 38-43.

Research output: Contribution to journalArticle

Ochi, J, Tsushima, T, Kobashi, K, Hara, M, Nasu, Y, Matsumura, Y, Ohmori, H, Asahi, T, Takeda, K, Oheda, T, Josen, T, Shiraga, T, Ike, N, Akaeda, T, Nanba, K, Tanahashi, T, Takamoto, H, Akazawa, N & Hayata, S 1994, 'Clinicostatistical study of renal pelvic and ureteral tumors', Nishinihon Journal of Urology, vol. 56, no. 1, pp. 38-43.
Ochi J, Tsushima T, Kobashi K, Hara M, Nasu Y, Matsumura Y et al. Clinicostatistical study of renal pelvic and ureteral tumors. Nishinihon Journal of Urology. 1994;56(1):38-43.
Ochi, J. ; Tsushima, T. ; Kobashi, K. ; Hara, M. ; Nasu, Yasutomo ; Matsumura, Y. ; Ohmori, H. ; Asahi, T. ; Takeda, K. ; Oheda, T. ; Josen, T. ; Shiraga, T. ; Ike, N. ; Akaeda, T. ; Nanba, K. ; Tanahashi, T. ; Takamoto, H. ; Akazawa, N. ; Hayata, S. / Clinicostatistical study of renal pelvic and ureteral tumors. In: Nishinihon Journal of Urology. 1994 ; Vol. 56, No. 1. pp. 38-43.
@article{38d6f1f99c4440ce97b9f32bc9aea2cc,
title = "Clinicostatistical study of renal pelvic and ureteral tumors",
abstract = "From 1975 to 1984, 190 patients with renal pelvic tumor and ureteral tumor were treated at our hospitals. With reference to those cases (renal pelvic tumor, 85 cases; ureteral tumor, 83 cases; renal pelvic and ureteral tumor, 22 cases), mainly the effects of adjuvant chemotherapy were analyzed in this study. The survival rate of all the cases was 54.5{\%} at 5 years. To evaluate the effects of adjuvant chemotherapy, the survival rates of two groups (those with or without adjuvant chemotherapy) were compared. For the patients (M(o), (p)T(a)~(p)T4), the survival rates at 5 years were 67.8{\%} for the chemotherapy (+) group and 50.7{\%} for the chemotherapy (-) group. There was no significant difference between the two groups. For the patients (M(o), (p)T(a)~(p)T2), the survival rates were 80.6{\%} and 48.5{\%}, respectively and there was a significant difference (p2, G3) the survival rates were 81.4{\%} and 0{\%}, respectively, and this showed an even more significant difference (p",
author = "J. Ochi and T. Tsushima and K. Kobashi and M. Hara and Yasutomo Nasu and Y. Matsumura and H. Ohmori and T. Asahi and K. Takeda and T. Oheda and T. Josen and T. Shiraga and N. Ike and T. Akaeda and K. Nanba and T. Tanahashi and H. Takamoto and N. Akazawa and S. Hayata",
year = "1994",
language = "English",
volume = "56",
pages = "38--43",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "1",

}

TY - JOUR

T1 - Clinicostatistical study of renal pelvic and ureteral tumors

AU - Ochi, J.

AU - Tsushima, T.

AU - Kobashi, K.

AU - Hara, M.

AU - Nasu, Yasutomo

AU - Matsumura, Y.

AU - Ohmori, H.

AU - Asahi, T.

AU - Takeda, K.

AU - Oheda, T.

AU - Josen, T.

AU - Shiraga, T.

AU - Ike, N.

AU - Akaeda, T.

AU - Nanba, K.

AU - Tanahashi, T.

AU - Takamoto, H.

AU - Akazawa, N.

AU - Hayata, S.

PY - 1994

Y1 - 1994

N2 - From 1975 to 1984, 190 patients with renal pelvic tumor and ureteral tumor were treated at our hospitals. With reference to those cases (renal pelvic tumor, 85 cases; ureteral tumor, 83 cases; renal pelvic and ureteral tumor, 22 cases), mainly the effects of adjuvant chemotherapy were analyzed in this study. The survival rate of all the cases was 54.5% at 5 years. To evaluate the effects of adjuvant chemotherapy, the survival rates of two groups (those with or without adjuvant chemotherapy) were compared. For the patients (M(o), (p)T(a)~(p)T4), the survival rates at 5 years were 67.8% for the chemotherapy (+) group and 50.7% for the chemotherapy (-) group. There was no significant difference between the two groups. For the patients (M(o), (p)T(a)~(p)T2), the survival rates were 80.6% and 48.5%, respectively and there was a significant difference (p2, G3) the survival rates were 81.4% and 0%, respectively, and this showed an even more significant difference (p

AB - From 1975 to 1984, 190 patients with renal pelvic tumor and ureteral tumor were treated at our hospitals. With reference to those cases (renal pelvic tumor, 85 cases; ureteral tumor, 83 cases; renal pelvic and ureteral tumor, 22 cases), mainly the effects of adjuvant chemotherapy were analyzed in this study. The survival rate of all the cases was 54.5% at 5 years. To evaluate the effects of adjuvant chemotherapy, the survival rates of two groups (those with or without adjuvant chemotherapy) were compared. For the patients (M(o), (p)T(a)~(p)T4), the survival rates at 5 years were 67.8% for the chemotherapy (+) group and 50.7% for the chemotherapy (-) group. There was no significant difference between the two groups. For the patients (M(o), (p)T(a)~(p)T2), the survival rates were 80.6% and 48.5%, respectively and there was a significant difference (p2, G3) the survival rates were 81.4% and 0%, respectively, and this showed an even more significant difference (p

UR - http://www.scopus.com/inward/record.url?scp=0027976901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027976901&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027976901

VL - 56

SP - 38

EP - 43

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 1

ER -